An Open-label Study Evaluating the Maintenance of Clinical Effect in Adult Schizophrenia Patients Switched From Risperidone Tablets to an Equivalent Dose of a Rapidly-dissolving Tablet Formulation of Risperdone
Clinical trial NCT00246272 · COMPLETED
Trial details
- NCT number
- NCT00246272
- Sponsor
- Janssen-Ortho Inc., Canada
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.